Additional efficacy results from RELATIVITY-047 evaluating the fixed-dose combination of relatlimab and nivolumab vs. Opdivo monotherapy in previously untreated metastatic or unresectable melanoma.
validation enforced?
Additional efficacy results from RELATIVITY-047 evaluating the...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.3¢ |
Change
0.003(0.81%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.5¢ | 30.5¢ | $179.4K | 576.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 327666 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 181725 | 24 |
View Market Depth
| Last trade - 14.33pm 04/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |